Doctor gives bad news to patient

(Photo by G-Stock Studio on Shutterstock)

In A Nutshell

  • About one in ten cancer patients developed a new mental health disorder, most often anxiety or depression, within a year of their diagnosis.
  • Those patients were 51% more likely to die from any cause in the roughly three years that followed, compared to patients who did not develop a mental health condition.
  • Pancreatic cancer patients were more than three times as likely to develop a mental health disorder after diagnosis compared to prostate cancer patients, reflecting how strongly prognosis shapes psychological response.
  • Mental health screening guidelines for cancer patients already exist but are not consistently applied, and this study adds weight to calls for earlier, more routine intervention.

A cancer diagnosis upends every aspect of an individual’s life, from sleep and appetite to work and relationships. All of it shifts the moment a doctor delivers that news. Now, a sweeping study finds how a patient reacts to such news may influence their risk of dying sooner.

Researchers found that cancer patients who developed anxiety, depression, or another mental health disorder within the first year of their diagnosis were 51% more likely to die from any cause during the roughly three years that followed, specifically months 12 through 35 after diagnosis, than patients who did not.

That figure comes from an analysis of nearly 372,000 cancer patients across the University of California health system, one of the largest studies of its kind ever conducted in the United States. The findings were published in Cancer, the peer-reviewed journal of the American Cancer Society. What sets this study apart from earlier work is its foundation.

Instead of relying on patient surveys or self-reported symptoms, researchers used clinically documented diagnoses pulled directly from a decade’s worth of hospital records. These were conditions a doctor confirmed, not just feelings a patient described on a questionnaire. It’s worth noting that the study is observational, meaning it identifies an association between mental health disorders and earlier death, but cannot prove that one directly causes the other.

When a Cancer Diagnosis Triggers a Mental Health Crisis

Researchers pulled records from all University of California-affiliated hospitals, tracking adult patients newly diagnosed with cancer between 2013 and 2023. To keep the analysis clean, only patients with no prior mental health history were included. The question was simple: how many would develop a new psychological condition, such as an anxiety disorder, depression, or a psychotic disorder, within 12 months of learning they had cancer?

About one in ten did. Of the nearly 372,000 patients studied, roughly 39,700 received a new mental health diagnosis within that first year. Generalized anxiety disorder was the most common, making up 43% of new cases. Major depressive disorder came next at 35.5%, followed by reactive and adjustment disorder at around 10.5%.

The timing of these diagnoses was itself revealing. Mental health conditions started ticking upward about three months before a cancer diagnosis was even officially recorded, likely because patients were already living with symptoms that sent them to a doctor in the first place. Then came a sharp spike in the six months right after the cancer diagnosis landed. That concentrated early window became the heart of what researchers wanted to study.

cancer patient
Pancreatic cancer patients were over three times as likely to develop a new mental health condition in comparison to prostate cancer patients. (Credit: GBJSTOCK on Shutterstock)

Mental Health and Cancer Survival: The Numbers Behind the Risk

In the first 12 to 35 months after diagnosis, patients who developed a mental health condition were 51% more likely to die from any cause than those who did not, even after researchers accounted for age, sex, race, and other existing health conditions. That’s a substantial gap.

It didn’t last forever. By years three through five, that elevated risk dropped to 17% above average. By years five through ten, the difference had essentially vanished. The association between mental health disorders and survival was strongest early on, hitting hardest in that vulnerable early stretch.

For patients who developed a mental health disorder and were also prescribed medication for it, antidepressants, anti-anxiety drugs, or antipsychotics, the early mortality risk was steeper still, more than double that of patients with no mental health diagnosis. Researchers suggest this may reflect how severe those cases were, since doctors typically prescribe psychotropic medications for moderate to severe symptoms. However, because the study did not include data on cancer stage or why specific medications were prescribed, it cannot determine whether the higher risk reflects symptom severity, more advanced cancer, or other factors entirely.

Not All Cancers Hit the Same Way

The type of cancer a patient had mattered too. Pancreatic cancer patients, who face a disease with roughly an 11% five-year survival rate, were more than three times as likely to develop a new mental health condition compared to prostate cancer patients, who served as the study’s comparison group. That gap makes sense intuitively. A diagnosis with a brutal prognosis generates a different kind of fear than one with high survival odds. But mapping that intuition across hundreds of thousands of patients gives it a weight that gut feeling alone cannot.

Among patients who did develop a mental health condition in that first year, breast cancer was the most commonly represented cancer type at 16.6% of that group, followed by blood cancers like leukemia and lymphoma at 13.3%.

A Prescribing Pattern Worth Examining

Of the patients who received a new mental health diagnosis, 35% were prescribed at least one psychotropic medication. Benzodiazepines, sedatives like Valium and Xanax, turned out to be the most commonly prescribed, with nearly a quarter of all cancer patients in the cohort receiving one at some point. That rate ran well ahead of SSRIs, the antidepressant class that clinical guidelines generally recommend first for anxiety and depression.

Researchers flagged that as worth paying attention to. The study did not test whether benzodiazepines directly increased mortality in this group, but the authors noted that prior research has linked these drugs to higher mortality risk and adverse interactions in patients with serious medical conditions, raising questions about whether cancer patients are consistently getting the most appropriate psychiatric care.

That still leaves roughly two-thirds of patients who received a mental health diagnosis but no medication at all. Access, personal preference, or clinical judgment could all explain that, and the data cannot say which. What the data can say is that mental health conditions after a cancer diagnosis are common, cluster in a specific and early window, and are associated with measurable consequences for survival.

Why Earlier Mental Health Screening After Cancer Could Save Lives

Researchers also pointed out that even the numbers they found likely undercount the real problem. Patients who are struggling but never see a mental health provider would not appear anywhere in clinical records. The true psychological burden in this population is probably higher than what any hospital chart reflects.

As the authors wrote, the findings “reinforce and emphasize existing recommendations for prompt screening and management of distress and mental health following a cancer diagnosis.” Those guidelines already exist. Applying them consistently, especially in that first six months after diagnosis when the risk spikes sharply, is where the real work lies.


Disclaimer: This article is based on an observational study and does not establish that mental health disorders directly cause earlier death in cancer patients. The findings reflect associations identified in a large patient dataset. Anyone experiencing mental health concerns following a cancer diagnosis should speak with a licensed healthcare provider.


Paper Notes

Limitations

The electronic health records used in the study did not include information on cancer stage or the specific treatments patients received, both of which could influence mental health outcomes and survival. The dataset also did not capture why specific psychotropic medications were prescribed, meaning some may have served non-mental health purposes, such as using an antidepressant to manage pain. Because mental health diagnoses were drawn from clinical records rather than direct psychological assessments, the actual prevalence of distress in this population is likely higher than the study reflects. Detailed cause-of-death data were not available, limiting the ability to separate cancer-specific deaths from deaths attributed to other causes. As an observational study, the research identifies associations between mental health disorders and mortality but cannot establish that one directly causes the other.

Funding and Disclosures

Analytical and technical support was provided by the Center for Data-Driven Insights and Innovation at the University of California Health, which maintains the UC Health Data Warehouse. The authors declared no conflicts of interest.

Publication Details

Authors: Amir Ashraf Ganjouei, MD, MPH; Travis Zack, MD, PhD; Isabel Friesner, BA; William C. Chen, MD; Lauren Boreta, MD; Steve E. Braunstein, MD, PhD; Michael W. Rabow, MD; Maria E. Garcia, MD, MPH; Julian C. Hong, MD, MS. All affiliated with the University of California, San Francisco. | Journal: Cancer (published by Wiley Periodicals LLC on behalf of the American Cancer Society) | Paper Title: “Association of mental health disorders and all-cause mortality for patients with cancer: Large-scale analysis of University of California Health System Data” | DOI: 10.1002/cncr.70254 | Published: 2026

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment